<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The study was based on the follow-up of 20 patients with systemic <z:hpo ids='HP_0005681'>juvenile rheumatoid arthritis</z:hpo> who received intravenous immunoglobulin </plain></SENT>
<SENT sid="1" pm="."><plain>The study comparatively analyzed the efficiency of the therapy alone and in combination with steroids </plain></SENT>
<SENT sid="2" pm="."><plain>The immunoglobulin was shown to have positive effects on both articular and extraarticular manifestations of the disease particularly in a group of children untreated with <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>The duration of the disease did not affect the therapeutical properties of immunoglobulin </plain></SENT>
</text></document>